12/5
02:39 pm
vktx
Viking: Results From 2 Clinical Trials Of Weight Loss Drug Ahead, Other Catalysts On Tap [Seeking Alpha]
Low
Report
Viking: Results From 2 Clinical Trials Of Weight Loss Drug Ahead, Other Catalysts On Tap [Seeking Alpha]
12/4
11:20 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $32.00 price target on the stock.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $32.00 price target on the stock.
12/4
09:31 am
vktx
Thinking about trading options or stock in Tesla, Pfizer, Super Micro Computer, Viking Therapeutics, or Coinbase Global?
Medium
Report
Thinking about trading options or stock in Tesla, Pfizer, Super Micro Computer, Viking Therapeutics, or Coinbase Global?
12/4
08:32 am
vktx
RIOT, VKTX and FREY are among pre market gainers [Seeking Alpha]
Medium
Report
RIOT, VKTX and FREY are among pre market gainers [Seeking Alpha]
12/4
04:19 am
vktx
Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to Take Advantage [Yahoo! Finance]
High
Report
Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer — Here Are 2 Stocks to Take Advantage [Yahoo! Finance]
11/28
07:42 am
vktx
Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 74% of the company [Yahoo! Finance]
Low
Report
Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 74% of the company [Yahoo! Finance]
11/13
04:12 pm
vktx
Viking Therapeutics Presents New Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) at The Liver Meeting® 2023 [Yahoo! Finance]
High
Report
Viking Therapeutics Presents New Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) at The Liver Meeting® 2023 [Yahoo! Finance]
11/13
04:02 pm
vktx
Viking Therapeutics Presents New Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) at The Liver Meeting® 2023
High
Report
Viking Therapeutics Presents New Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) at The Liver Meeting® 2023
11/2
04:03 pm
vktx
Viking Therapeutics to Participate at Upcoming Investor Conferences
Medium
Report
Viking Therapeutics to Participate at Upcoming Investor Conferences
10/25
06:37 pm
vktx
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
10/25
04:05 pm
vktx
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Medium
Report
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
10/23
07:05 am
vktx
Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
Low
Report
Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
10/18
04:05 pm
vktx
Viking Therapeutics to Report Financial Results for Third Quarter 2023 on October 25, 2023
Low
Report
Viking Therapeutics to Report Financial Results for Third Quarter 2023 on October 25, 2023
10/18
09:31 am
vktx
Thinking about buying stock in Tempest Therapeutics, VinFast Auto, AGNC Investment, Ardelyx, or Viking Therapeutics?
Medium
Report
Thinking about buying stock in Tempest Therapeutics, VinFast Auto, AGNC Investment, Ardelyx, or Viking Therapeutics?
10/18
05:44 am
vktx
Biggest stock movers today: United Airlines, Viking Therapeutics and more [Seeking Alpha]
Low
Report
Biggest stock movers today: United Airlines, Viking Therapeutics and more [Seeking Alpha]
10/17
07:52 pm
vktx
Stocks to Watch: United Airlines, J.B. Hunt, Viking Therapeutics [MarketWatch]
High
Report
Stocks to Watch: United Airlines, J.B. Hunt, Viking Therapeutics [MarketWatch]
10/17
04:05 pm
vktx
Viking Therapeutics Presents New Data from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Oral Presentation at ObesityWeek 2023
Medium
Report
Viking Therapeutics Presents New Data from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Oral Presentation at ObesityWeek 2023
10/10
04:05 pm
vktx
Viking Therapeutics to Highlight Data from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Oral Presentation at ObesityWeek 2023
Low
Report
Viking Therapeutics to Highlight Data from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Oral Presentation at ObesityWeek 2023
10/4
09:03 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.
10/2
01:42 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $32.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $32.00 price target on the stock.
9/21
12:03 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.
9/8
09:05 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.
9/7
04:05 pm
vktx
Viking Therapeutics to Participate at Upcoming Investor Conferences
Medium
Report
Viking Therapeutics to Participate at Upcoming Investor Conferences